|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
13.890 +0.430 (+3.195%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,391,116 | 151,048 | 1,354,099 | (201,970) |
| Net Cash from / (used in) Investing Activities | -- | (1,050,092) | 1,087,807 | 68,306 | (435,503) |
| Net Cash from / (used in) Financing Activities | -- | (407,403) | (894,834) | (753,681) | (1,624,531) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (66,379) | 344,021 | 668,724 | (2,262,004) |
| Cash & Cash Equivalents at beginning of period | -- | 2,007,162 | 1,658,312 | 974,464 | 3,270,241 |
| Effect of Foreign Exchange Rate Changes | -- | 2,286 | 4,829 | 15,124 | (35,098) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,943,069 | 2,007,162 | 1,658,312 | 973,139 |
| Remarks: | Real time quote last updated: 12/09/2025 14:08 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 603,607 |
| %Change | 32.196% |
| EPS / (LPS) | RMB 0.250 |
| NBV Per Share (¥) | RMB 2.923 |